Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Growth Factors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01372384
What this trial is testing

Tarceva (Erlotinib) in Patients With Locally Advanced, Metastatic or Recurrent Non-Small Cell Cancer Who Present Epidermal Growth Factor Receptor Mutations

Who this might be right for
Non-Squamous Non-Small Cell Lung Cancer
Hoffmann-La Roche 6
Early research (Phase 1)Study completedNCT00647114
What this trial is testing

Test V930/V932 in Patients With Cancers Expressing Human Epidermal Growth Factor Receptor 2 (HER-2) and/or Carcinoembryonic Antigen (CEA)(V930-003)(COMPLETED)

Who this might be right for
Cancer
Merck Sharp & Dohme LLC 41
Testing effectiveness (Phase 2)Study completedNCT02239731
What this trial is testing

Safety, Tolerability and Efficacy Study of Doxycycline Foam for the Prevention of EGFRI Skin Toxicity in Cancer Patients

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Vyne Therapeutics Inc. 24
Testing effectiveness (Phase 2)Study completedNCT03007992
What this trial is testing

Metronomic Treatment With Daily Oral Vinorelbine as First-line Chemotherapy in Patients With Advanced/Metastatic Hormone Receptor Positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Breast Cancer

Who this might be right for
Metastatic Breast Cancer
Johannes Gutenberg University Mainz 9
Not applicableLooking for participantsNCT07546695
What this trial is testing

Role of Axillary Lymph Node Dissection for Residual MACROMETASTASES After NEOADJUVANT Chemotherapy in Patients With HER2+ and Triple Negative Breast Cancer: The OPBC-11/MACRONAC Study

Who this might be right for
Breast Cancer
University Hospital, Basel, Switzerland 600
Not applicableStudy completedNCT01446302
What this trial is testing

Metabolic and Inflammatory Responses to Hemodialysis and the Effect of a Meal

Who this might be right for
Kidney Failure, Chronic
University of Aarhus 24
Testing effectiveness (Phase 2)Study completedNCT01763307
What this trial is testing

Examine the Effect of Reconval K1 Cream to Prevent Skin Toxicity From EGFRI

Who this might be right for
Rash Due to Epidermal Growth Factor Receptor Inhibitors
Hadassah Medical Organization 18
Testing effectiveness (Phase 2)Active Not RecruitingNCT05077800
What this trial is testing

FOLFIRINOX + Elraglusib + Losartan In Pancreatic Cancer

Who this might be right for
Pancreatic AdenocarcinomaPancreatic Adenocarcinoma Metastatic
Colin D. Weekes, M.D., PhD 70
Post-approval studies (Phase 4)Study completedNCT01877512
What this trial is testing

GH and Cardiovascular Risk Factors

Who this might be right for
Growth Hormone DeficiencyCardiovascular DiseasesMetabolic Syndrome+2 more
Amsterdam UMC, location VUmc 32
Testing effectiveness (Phase 2)Study completedNCT00719212
What this trial is testing

Study of AMG 479 as Second Line Therapy in Patients With Recurrent Platinum-sensitive Ovarian Cancer

Who this might be right for
Ovarian Neoplasms
Translational Research in Oncology 61
Testing effectiveness (Phase 2)Study completedNCT01736410
What this trial is testing

Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer

Who this might be right for
HER 2 Positive Advanced Gastric Cancer
National Cancer Centre, Singapore 30
Testing effectiveness (Phase 2)Study completedNCT00067860
What this trial is testing

Diet/Growth Factor Mechanisms of Gut Adaptation

Who this might be right for
Short Bowel Syndrome
Emory University 27
Not applicableEnded earlyNCT00504218
What this trial is testing

Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors and Hematopoietic Stem Cell Transplant Recipients

Who this might be right for
HypopituitarismHypogonadismThyroid Dysfunction+1 more
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 62
Testing effectiveness (Phase 2)UnknownNCT03904823
What this trial is testing

Famitinib in Combination With HS-10296 in Patients With EGFR-mutant NSCLC

Who this might be right for
EGFR-mutant Non-Small Cell Lung Cancer
Jiangsu HengRui Medicine Co., Ltd. 58
Testing effectiveness (Phase 2)Study completedNCT01783444
What this trial is testing

A Phase II Study of Everolimus in Combination With Exemestane Versus Everolimus Alone Versus Capecitabine in Advance Breast Cancer.

Who this might be right for
Breast Cancer
Novartis Pharmaceuticals 309
Large-scale testing (Phase 3)Looking for participantsNCT06008106
What this trial is testing

Comparing Tunlametinib Capsules and Combination Chemotherapy in Advanced NRAS-mutant Melanoma

Who this might be right for
Melanoma
Shanghai Kechow Pharma, Inc. 165
Not applicableNot Yet RecruitingNCT07714304
What this trial is testing

JS212 in Combination With JS111 as First-Line Treatment in EGFR-Mutant Advanced NSCLC

Who this might be right for
NSCLC Harboring EGFR Mutations
Huan Zhou 20
Large-scale testing (Phase 3)Study completedNCT01217463
What this trial is testing

The TRAfermin in Neuropathic Diabetic Foot Ulcer Study - Southern Europe The TRANS-South Study

Who this might be right for
Diabetic Foot Ulcer of Neuropathic Origin
Olympus Biotech Corporation 201
Testing effectiveness (Phase 2)Study completedNCT02101281
What this trial is testing

Safety and Efficacy of rhNGF Eye Drops at Different Doses in Patients With Dry Eye

Who this might be right for
Dry Eye Syndrome
Dompé Farmaceutici S.p.A 40
Testing effectiveness (Phase 2)Study completedNCT05963984
What this trial is testing

Samuraciclib in Combination With Fulvestrant in Metastatic or Locally Advanced Breast Cancer in Adult Participants

Who this might be right for
Metastatic Breast CancerLocally Advanced Breast CancerBreast Cancer
Carrick Therapeutics Limited 60
Next Page